These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 32122339)

  • 1. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
    Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
    Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
    Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross sectional study.
    Kamga SLS; Ali IM; Ngangnang GR; Ulucesme MC; Keptcheu LTD; Keming EM; Tchuenkam VK; Foyet JV; Aktas M; Noubom M; Payne VK
    Malar J; 2024 Jan; 23(1):6. PubMed ID: 38178125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
    Arnaldo P; Rovira-Vallbona E; Langa JS; Salvador C; Guetens P; Chiheb D; Xavier B; Kestens L; Enosse SM; Rosanas-Urgell A
    Malar J; 2018 Mar; 17(1):109. PubMed ID: 29530044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
    Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
    Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact on pregnancy outcomes of intermittent preventive treatment with sulfadoxine-pyrimethamine in urban and peri-urban Papua New Guinea: a retrospective cohort study.
    Cellich P; Unger HW; Rogerson SJ; Mola GDL
    Malar J; 2024 Jul; 23(1):201. PubMed ID: 38970076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.
    Okethwangu D; Opigo J; Atugonza S; Kizza CT; Nabatanzi M; Biribawa C; Kyabayinze D; Ario AR
    Malar J; 2019 Jul; 18(1):250. PubMed ID: 31349829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.
    Verhoeff FH; Brabin BJ; Chimsuku L; Kazembe P; Russell WB; Broadhead RL
    Ann Trop Med Parasitol; 1998 Mar; 92(2):141-50. PubMed ID: 9625909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
    Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
    PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
    Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U
    Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudinal study.
    Apinjoh TO; Ntui VN; Chi HF; Moyeh MN; Toussi CT; Mayaba JM; Tangi LN; Kwi PN; Anchang-Kimbi JK; Dionne-Odom J; Tita ATN; Achidi EA; Amambua-Ngwa A; Titanji VPK
    PLoS One; 2022; 17(9):e0275370. PubMed ID: 36178962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.